Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-685-9 | CAS number: 124-17-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Repeated dose toxicity: dermal
Administrative data
- Endpoint:
- sub-chronic toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1993
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: A well conducted study where key information is reported.
Cross-reference
- Reason / purpose for cross-reference:
- reference to same study
Reference
- Endpoint:
- one-generation reproductive toxicity
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- 1993
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Reason / purpose for cross-reference:
- reference to same study
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 415 [One-Generation Reproduction Toxicity Study (before 9 October 2017)]
- Deviations:
- yes
- Remarks:
- Animals treated for 13 weeks prior to mating. Not all end points examined
- GLP compliance:
- not specified
- Limit test:
- yes
- Species:
- rat
- Strain:
- other: Charles River CD
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories
- Age at study initiation: 6 wks
- Housing: individual in suspended stainless steel cages, except during mating and lactation period. During latter, solid steel pan fitted and hardwood shaving bedding added.
- Use of restrainers for preventing ingestion (if dermal): no data
- Diet (ad libitum): Certified Purina lab chow #5002 mash diet
- Water (ad libitum): tap
- Acclimation period: 2 weeks
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19-24
- Humidity (%): 30-70
- Photoperiod (hrs dark / hrs light): 12/12 - Route of administration:
- dermal
- Vehicle:
- unchanged (no vehicle)
- Details on exposure:
- TEST SITE
- Area of exposure: back
- % coverage: 3x3cm
- Type of wrap if used: polyethylene (PE) patch held in place by adhesive bandage wrapped around trunk of animal. Gauze pad added beneath PE patch after start of study
- Time intervals for shavings or clipplings:
REMOVAL OF TEST SUBSTANCE
- Washing (if done): wiped only.
- Time after start of exposure: 6hrs
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 2ml/kg bw/day based on an assumed density of 1g/ml (ie therefore 2g/kg bw/day.
- Concentration (if solution): neat
- Constant volume or concentration used: yes
USE OF RESTRAINERS FOR PREVENTING INGESTION: no data - Details on mating procedure:
- - M/F ratio per cage: 1:1
- Length of cohabitation: overnight
- Proof of pregnancy: vaginal plug or sperm in vaginal smear
- After 10 days of unsuccessful pairing replacement of first male by another male with proven fertility.
- After successful mating each pregnant female was caged as previously until littering
- Any other deviations from standard protocol: No crossover was used. Mating only control/control and treatment/treatment male/females. - Analytical verification of doses or concentrations:
- no
- Details on analytical verification of doses or concentrations:
- Not required as neat substance used.
- Duration of treatment / exposure:
- Exposure period: 90 days.
Premating exposure period (males): 90 days
Premating exposure period (females): 90 days
Females then treated throughout gestation and lactation period - Frequency of treatment:
- 6 hours/day, 5 day/week and then daily except for females during GD0-20 when 7 days/week
- Details on study schedule:
- no further information
- Dose / conc.:
- 2 000 mg/kg bw/day
- No. of animals per sex per dose:
- 25
- Control animals:
- other: yes, sham treatment with distilled water
- Details on study design:
- - Rationale for animal assignment (if not random): randomised but to keep mean body weights of control and treatment groups equal.
- Positive control:
- no
- Parental animals: Observations and examinations:
- BODY WEIGHT: Yes
- Mated females on GD0, 7, 14, 20 and lactating females on days 0, 7, 21 postpartum.
FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study):
- Food consumption monitored during each third of gestation period. - Oestrous cyclicity (parental animals):
- Estrous cyclicity was monitored in a parallel repeat dose toxicity study. See section on cross references.
- Sperm parameters (parental animals):
- Not examined
- Litter observations:
- STANDARDISATION OF LITTERS
- Performed on day 4 postpartum: yes
- If yes, maximum of 8 pups/litter (4/sex/litter as nearly as possible); excess pups were killed and discarded.
PARAMETERS EXAMINED
The following parameters were examined in F1 offspring: number and sex of pups, presence of gross anomalies (monitored throughout lactation, weight gain.
GROSS EXAMINATION OF DEAD PUPS:
yes, for external abnormalities - Postmortem examinations (parental animals):
- SACRIFICE (by exsanguination)
- Male animals: All surviving animals after completion of mating period.
- Maternal animals: All surviving animals after the last litter of each generation was weaned.
GROSS NECROPSY. Yes but no further details
HISTOPATHOLOGY / ORGAN WEIGHTS. Yes but selective
- Testes, epididymides, seminal vesicles, prostate glands and any gross lesions were prepared for microscopic examination. - Postmortem examinations (offspring):
- SACRIFICE (ether overdose)
- on lactation day 21
GROSS NECROPSY
- Gross necropsy consisted of external and internal examinations - Statistics:
- Body weights, feed consumption, organ weights using Bartlett's test to determine if variances equal. If variances equal, parametric procedures used (ANOVA followed by Dunnett's test if appropriate). Alternative non-parametric procedures were Kruskal-Wallis test follwed by Dunn's summed rank test if appropriate. Tests for trend using regression analysis and Jonckheere's test. Walsh's test used to determine equality of means. Indices compared using Fisher's exact test. Comparisons made at 1 and 5% signficance levels (two sided.)
- Reproductive indices:
- Mating indices, pregnancy rates, male fertility
- Offspring viability indices:
- Survival
- Clinical signs:
- not specified
- Dermal irritation (if dermal study):
- effects observed, treatment-related
- Description (incidence and severity):
- Dermal irritation occurred at the application site.
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- no effects observed
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Histopathological findings: non-neoplastic:
- no effects observed
- Description (incidence and severity):
- No effects on testes
- Reproductive function: oestrous cycle:
- no effects observed
- Description (incidence and severity):
- Results drawn from parallel repeat dose toxicity study where vaginal cytology was assessed.
- Reproductive function: sperm measures:
- not examined
- Reproductive performance:
- no effects observed
- Description (incidence and severity):
- No effects on male and female mating indices, pregnancy rates, male fertility indices.
- Remarks on result:
- not determinable due to absence of adverse toxic effects
- Critical effects observed:
- no
- Clinical signs:
- not specified
- Mortality / viability:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Sexual maturation:
- not specified
- Organ weight findings including organ / body weight ratios:
- not specified
- Gross pathological findings:
- no effects observed
- Histopathological findings:
- not specified
- Reproductive effects observed:
- no
- Conclusions:
- There was no evidence of reproductive toxicity resulting from treatment of rats with 2-(2-butoxyethoxy)ethanol with a dermally applied dose of 2000mg/kg bw/day
- Executive summary:
In a well conducted single generation fertility study, 2 -(2 -butoxyethoxy)ethanol produced no signs of toxicity to reproduction in either male or female rats when tested with a dermally dose of 2000mg/kg bw/day. The only finding that was dermal irritation resulting from repeated application of the test substance to the same application site.
Synopsis
Not toxic to reproduction
Data source
Reference
- Reference Type:
- publication
- Title:
- Toxicology of diethylene glycol butyl ether 4. Dermal subchronic/reproduction study
- Author:
- Auletta CS, Schroeder RE, Krasavage WJ, Stack CR
- Year:
- 1 993
- Bibliographic source:
- J Am coll. Toxicol. 12, 2, 161-168.
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 411 (Subchronic Dermal Toxicity: 90-Day Study)
- Deviations:
- yes
- Remarks:
- , not all end points apparently recorded
- GLP compliance:
- not specified
- Limit test:
- no
Test material
- Reference substance name:
- 2-(2-butoxyethoxy)ethanol
- EC Number:
- 203-961-6
- EC Name:
- 2-(2-butoxyethoxy)ethanol
- Cas Number:
- 112-34-5
- Molecular formula:
- C8H18O3
- IUPAC Name:
- 2-(2-butoxyethoxy)ethanol
- Details on test material:
- - Name of test material (as cited in study report): ethylene glycol monobutyl ether (DGBE)
- Physical state: liquid
- Analytical purity: no data
- Stability under test conditions: confirmed a homogeneous and stable for 1 week
- Storage condition of test material: under nitrogen in refridgerator
- Other: supplied by Dow Chemical Co.
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: Charles River CD
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories
- Age at study initiation: 6 wks
- Housing: individual in suspended stainless steel cages, except during mating and lactation period. During latter, solid steel pan fitted and hardwood shaving bedding added.
- Use of restrainers for preventing ingestion (if dermal): no data
- Diet (ad libitum): Certified Purina lab chow #5002 mash diet
- Water (ad libitum): tap
- Acclimation period: 2 weeks
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19-24
- Humidity (%): 30-70
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Type of coverage:
- occlusive
- Vehicle:
- water
- Details on exposure:
- TEST SITE
- Area of exposure: back
- % coverage: 3x3cm
- Type of wrap if used: polyethylene (PE) patch held in place by adhesive bandage wrapped around trunk of animal. Gauze pad added beneath PE patch after start of study
- Time intervals for shavings or clipplings:
REMOVAL OF TEST SUBSTANCE
- Washing (if done): wiped only.
- Time after start of exposure: 6hrs
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 2ml/kg
- Concentration (if solution): neat
- Constant volume or concentration used: yes - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Periodic analysis of diluted dosing solutions showed that 10% dose within 99.5(+/-3.1)% and 30% dose within 99.8(+/-2.6)%.
- Duration of treatment / exposure:
- 13 weeks
- Frequency of treatment:
- 6 hours/day, 5 days/week
Doses / concentrationsopen allclose all
- Dose / conc.:
- 200 mg/kg bw/day
- Dose / conc.:
- 600 mg/kg bw/day
- Dose / conc.:
- 2 000 mg/kg bw/day
- No. of animals per sex per dose:
- 10
- Control animals:
- yes
- Details on study design:
- - Rationale for animal assignment (if not random): randomised but to keep mean body weights of control and treatment groups equal.
- other: Post-exposure period: none - Positive control:
- no
Examinations
- Observations and examinations performed and frequency:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: twice daily checks for morbidity/mortality and overt toxic effects
DETAILED CLINICAL OBSERVATIONS: No data
DERMAL IRRITATION (if dermal study): Yes
- Time schedule for examinations: twice daily qualitative analysis at treatment (dosing) time and after wrapping removed.
BODY WEIGHT: Yes
- Time schedule for examinations: weekly
FOOD CONSUMPTION:
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: Yes, weekly
FOOD EFFICIENCY:
- Body weight gain in kg/food consumption in kg per unit time X 100 calculated as time-weighted averages from the consumption and body weight gain data: Yes / No / No data
OPHTHALMOSCOPIC EXAMINATION: Yes
- Time schedule for examinations: pre-study and near end study
HAEMATOLOGY:
- Time schedule for collection of blood: Pre-study and at 4 and 13 weeks. Collected by venipuncture of orbital sinus.
- Anaesthetic used for blood collection: Yes
- Animals fasted: Yes, overnight and not dosed until after blood collection.
- How many animals: no data
CLINICAL CHEMISTRY: Yes
- Time schedule for collection of blood: Pre-study and at 4 and 13 weeks. Collected by venipuncture of orbital sinus.
- Animals fasted: Yes, overnight
- How many animals: No data
URINALYSIS: Yes / No / No data
- Time schedule for collection of urine: Pre-study and at 4 and 13 weeks
- Metabolism cages used for collection of urine: No data
- Animals fasted: No data
NEUROBEHAVIOURAL EXAMINATION: No
OTHER: During a 14 day period near the end of the study, daily vaginal smears were collected to dermine if normal oestrus cycle was occuring. - Sacrifice and pathology:
- Sacrifice by ether anesthesia.
GROSS PATHOLOGY: Yes
HISTOPATHOLOGY: Yes, including adrenals, kidneys, pituitary, prostate, testes, epididymides, seminal vesicles, liver, ovaries and spleen. All weighed and fixed. High dose and control animal tissues sectioned for histology. - Other examinations:
- none
- Statistics:
- Body weights, feed consumption, organ weights using Bartlett's test to determine if variances equal. If variances equal, parametric procedures used (ANOVA followed by Dunnett's test if appropriate). Alternative non-parametric procedures were Kruskal-Wallis test follwed by Dunn's summed rank test if appropriate. Tests for trend using regression analysis and Jonckheere's test. Walsh's test used to determine equality of means. Comparisons made at 1 and 5% signficance levels (two sided.)
Results and discussion
Results of examinations
- Clinical signs:
- effects observed, treatment-related
- Description (incidence and severity):
- One mid and one high dose animal had haematuria or red urinary staining on the haircoat.
- Dermal irritation:
- effects observed, treatment-related
- Description (incidence and severity):
- Concentration dependent increase in irritation worse in females. In females it was evident (erythema) from week 1 at the high dose and week 8 at the mid and high dose, with increasing numbers of animals affected with time. In males, it was only seen at the end of the study and and never effected more than 50% of animals. In males the severity was slight or very slight whilst in females there was necrosis and eschar in some animals at high doses.
- Mortality:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- no effects observed
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- no effects observed
- Haematological findings:
- no effects observed
- Clinical biochemistry findings:
- no effects observed
- Urinalysis findings:
- effects observed, treatment-related
- Description (incidence and severity):
- Occult blood was noted in females treated at 600 or 2000 mg/kg but there was no evidence of urinary casts or significant numbers of erthyrocytes.
- Behaviour (functional findings):
- not examined
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Gross pathological findings:
- no effects observed
- Histopathological findings: non-neoplastic:
- no effects observed
- Histopathological findings: neoplastic:
- no effects observed
Effect levels
open allclose all
- Dose descriptor:
- NOAEL
- Effect level:
- < 200 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- dermal irritation
- Dose descriptor:
- NOAEL
- Effect level:
- > 2 000 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: all other effects
- Remarks on result:
- not determinable due to absence of adverse toxic effects
Target system / organ toxicity
- Critical effects observed:
- not specified
Any other information on results incl. tables
Females appeared to be more susceptible than males to concentration-dependent irritation at the application site. Effects at the highest dosage were desquamation, atonia, eschar and necrosis.
Applicant's summary and conclusion
- Conclusions:
- The only effect of note was dermal irritation at the site of repeated application which occured at all doses, albeit very slight at the low dose and only in males at towards the end of the study. Irritancy was more marked in females than males and produced some necrosis at the highest dose. There were no other adverse findings noted.
- Executive summary:
In a well conducted study designed to assess the sub-chronic and reproductive toxicity of 2 -(2 -butoxyethoxy)ethanol to rats, the test substance was administered by the dermal route for 13 weeks to the maximum practical concentration attainable of 2ml/kg. The only effect of note was dermal irritation at the site of repeated application which occured at all doses, albeit very slight at the low dose and only in males at towards the end of the study. Irritancy was more marked in females than males and produced some necrosis at the highest dose. There were no other adverse findings noted.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.